Florida / New York | ADVERTISE

A Publication for the Practising Medical Specialist, Industry Executive & Investor

Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States

Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!

“Medical Device News: Essential Key Insights and Noteworthy Developments Shaping the Future”

4 Key Criteria for High-Precision Medical Materials

Material choice is inseparable from the manufacturing process and the partner who will make your parts at scale. By prioritizing the key criteria, you reduce risk and speed validation. Choose a partner to move from uncertainty to certifiable results

Clinical Trials

Biotechnology News

Our Experts – Byline Articles

Read Their Views & Share With a Colleague or Two!

FDA Medical Device Updates

NEXTBIOMEDICAL Announces First Patient Enrolled in U.S. FDA Pivotal Trial of Nexsphere-F™ for Knee Osteoarthritis Pain

The study is designed to compare genicular artery embolization (GAE) with Nexsphere-F™ to intra-articular corticosteroid injections, with the primary goal of assessing both safety and efficacy in patients with painful knee osteoarthritis. Nexsphere-F™ has already received multiple key U.S. regulatory designations, including FDA Breakthrough Device Designation, CMS IDE Category B approval, and participation in the TAP (Total Product Lifecycle Advisory Program).

Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding

CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders

Oversubscribed Financing led by Coastlands Capital with participation from new and existing investors and the financing to provide $50 million in upfront proceeds with the potential for up to an additional $50 million of proceeds to fund the Phase 1/2 clinical trial in patients with SYNGAP1-related disorders, expected to initiate as early as 2H 2026

Market Reports

Advancements in Imaging

Hospitals In the News

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Deep Learning Model Estimates Cancer Risk of Lung Nodules

Lung cancer remains a significant global health issue, causing the most cancer-related deaths worldwide. Screening high-risk individuals with low-dose chest CT has been shown to reduce lung cancer mortality. However, early screening trials have reported high false-positive rates, leading to unnecessary follow-up procedures, increased patient anxiety and health care costs.

Healthcare - Understanding the Business Side of the Industry and Its Implications

Healthcare Careers

Nurses Corner

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.